Tobira Therapeutics, Inc. Operating Expenses
Tobira Therapeutics, Inc. reported Operating Expenses of $14.01 million for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-08-09
- Tobira Therapeutics, Inc. operating expenses for the quarter ending 2016-06-30 was $14.01M, a 43.89% increase year-over-year.
- Tobira Therapeutics, Inc. operating expenses for the quarter ending 2016-03-31 was $12.02M, a 53.65% increase year-over-year.
- Tobira Therapeutics, Inc. operating expenses for the quarter ending 2015-12-31 was $9.07M, a 0.82% increase year-over-year.
- Tobira Therapeutics, Inc. operating expenses for the quarter ending 2015-09-30 was $26.23M, a 644.62% increase year-over-year.
- Tobira Therapeutics, Inc. operating expenses for fiscal 2015 was $52.86M, a 164.01% increase from fiscal 2014.
- Tobira Therapeutics, Inc. operating expenses for fiscal 2014 was $20.02M, a 31.92% increase from fiscal 2013.
- Tobira Therapeutics, Inc. operating expenses for fiscal 2013 was $15.18M, a 24.78% increase from fiscal 2012.
- Tobira Therapeutics, Inc. operating expenses for fiscal 2012 was $12.16M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 142 month | Operating Expenses 145 month | Operating Expenses 148 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | $14.01M 10-Q · filed 2016-08-09 | $26.03M 10-Q · filed 2016-08-09 | $35.09M derived: sum of 3 quarters · filed 2016-08-09 | $61.33M derived: sum of 4 quarters · filed 2016-08-09 | |||||||
| 2016-03-31 | $12.02M 10-Q · filed 2016-05-09 | $21.09M derived: sum of 2 quarters · filed 2016-05-09 | $47.32M derived: sum of 3 quarters · filed 2016-05-09 | $57.05M derived: sum of 4 quarters · filed 2016-08-09 | |||||||
| 2015-12-31 | $9.07M 10-K · filed 2016-03-03 | $35.30M derived: sum of 2 quarters · filed 2016-03-03 | $45.03M derived: sum of 3 quarters · filed 2016-08-09 | $52.86M 10-K · filed 2016-03-03 | |||||||
| 2015-09-30 | $26.23M 10-K · filed 2016-03-03 | $35.97M derived: sum of 2 quarters · filed 2016-08-09 | $43.79M 10-Q · filed 2015-11-10 | $52.78M derived: sum of 4 quarters · filed 2016-08-09 | |||||||
| 2015-06-30 | $9.73M 10-Q · filed 2016-08-09 | $17.56M 10-Q · filed 2016-08-09 | $26.55M derived: sum of 3 quarters · filed 2016-08-09 | $30.07M derived: sum of 4 quarters · filed 2016-08-09 | |||||||
| 2015-03-31 | $7.82M 10-Q · filed 2016-05-09 | $7.89M 10-Q · filed 2015-04-29 | $16.82M derived: sum of 2 quarters · filed 2016-05-09 | $20.34M derived: sum of 3 quarters · filed 2016-05-09 | $25.31M derived: sum of 4 quarters · filed 2016-05-09 | ||||||
| 2014-12-31 | $8.99M 10-K · filed 2016-03-03 | $12.52M derived: sum of 2 quarters · filed 2016-03-03 | $17.48M derived: sum of 3 quarters · filed 2016-03-03 | $20.02M 10-K · filed 2016-03-03 | $66.63M 10-K · filed 2015-02-12 | ||||||
| 2014-09-30 | $3.52M 10-K · filed 2016-03-03 | $20.96M 10-Q · filed 2014-11-06 | $8.49M derived: sum of 2 quarters · filed 2016-03-03 | $11.03M 10-Q · filed 2015-11-10 | $57.97M 10-Q · filed 2014-11-06 | $6.37M derived: sum of 4 quarters · filed 2016-03-03 | |||||
| 2014-06-30 | $4.97M 10-K · filed 2016-03-03 | $21.34M 10-Q · filed 2014-08-11 | $7.50M 10-Q · filed 2015-08-11 | $37.01M 10-Q · filed 2014-08-11 | $2.85M derived: sum of 3 quarters · filed 2016-03-03 | $14.06M derived: sum of 4 quarters · filed 2016-03-03 | |||||
| 2014-03-31 | $2.54M 10-K · filed 2016-03-03 | $15.66M 10-Q · filed 2014-05-13 | -$2.12M derived: sum of 2 quarters · filed 2016-03-03 | $9.09M derived: sum of 3 quarters · filed 2016-03-03 | $14.54M derived: sum of 4 quarters · filed 2016-03-03 | $162.36M 10-Q · filed 2014-05-13 | |||||
| 2013-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $6.55M derived: sum of 2 quarters · filed 2016-03-03 | $12.00M derived: sum of 3 quarters · filed 2016-03-03 | $15.18M 10-K · filed 2016-03-03 | $33.84M 10-K · filed 2014-03-12 | $146.70M 10-K · filed 2014-03-12 | |||||
| 2013-09-30 | $11.21M 10-Q · filed 2014-11-06 | $16.66M derived: sum of 2 quarters · filed 2014-11-06 | $19.83M 10-Q · filed 2014-11-06 | $22.11M derived: sum of 4 quarters · filed 2014-11-06 | $132.69M 10-Q · filed 2013-11-08 | ||||||
| 2013-06-30 | $5.45M 10-Q · filed 2014-08-11 | $8.62M 10-Q · filed 2014-08-11 | $10.90M derived: sum of 3 quarters · filed 2014-08-11 | $13.48M derived: sum of 4 quarters · filed 2014-08-11 | |||||||
| 2013-03-31 | $3.18M 10-Q · filed 2014-05-13 | $5.45M derived: sum of 2 quarters · filed 2014-05-13 | $8.03M derived: sum of 3 quarters · filed 2014-05-13 | ||||||||
| 2012-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $4.86M derived: sum of 2 quarters · filed 2014-03-12 | $12.16M 10-K · filed 2014-03-12 | ||||||||
| 2012-09-30 | $2.58M 10-Q · filed 2013-11-08 | $9.89M 10-Q · filed 2013-11-08 |